MNLP – Module 8 – Final assessment
Assessment Summary
0 of 20 Questions completed
Questions:
Information
You have already completed the assessment before. Hence you can not start it again.
Assessment is loading…
You must sign in or sign up to start the assessment.
You must first complete the following:
Results
Results
0 of 20 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- Current
- Review
- Answered
- Correct
- Incorrect
- Question 1 of 20
1. Question
Is the following statement true or false:
Symptoms and complications arise solely as a result of the myeloma.
CorrectIncorrect - Question 2 of 20
2. Question
Which of the following is the least common presenting symptom or complication of myeloma?
CorrectIncorrect - Question 3 of 20
3. Question
What percentage of myeloma patients present with disease-related pain?
CorrectIncorrect - Question 4 of 20
4. Question
Which factor is associated with a lowering of pain tolerance?
CorrectIncorrect - Question 5 of 20
5. Question
Match the type of pain relief given to the grade of pain
Sort elements
- Chronic moderate to severe pain
- Mild pain
- Acute severe pain
- Mild to moderate pain
- A. High-dose tramadol, fentanyl patch, morphine
- B. Paracetamol, short-term NSAID
- C. Subcutaneous opioid therapy
- D. Low-dose tramadol, co-codamol, codeine
CorrectIncorrect - Question 6 of 20
6. Question
Leukopenia is a reduction in
CorrectIncorrect - Question 7 of 20
7. Question
Which of the following drugs is not considered to be associated with myelosuppression?
CorrectIncorrect - Question 8 of 20
8. Question
What haemoglobin level is graded as severe anaemia?
CorrectIncorrect - Question 9 of 20
9. Question
Patients presenting with symptoms of anaemia should be assessed for the following except
CorrectIncorrect - Question 10 of 20
10. Question
Routine antibiotic prophylaxis is usually recommended for which patients?
CorrectIncorrect - Question 11 of 20
11. Question
Bisphosphonate treatment is not recommended for myeloma patients if they have which complication?
CorrectIncorrect - Question 12 of 20
12. Question
Which of the following is not used to manage peripheral neuropathy caused by anti-myeloma treatment?
CorrectIncorrect - Question 13 of 20
13. Question
Which class of drug can increase the risk of a thromboembolic event?
CorrectIncorrect - Question 14 of 20
14. Question
Anaemia affects different systems of the body. Can you match the symptom to the correct system below?
Drag and drop one answer only to each category.
Sort elements
- Tachycardia
- Fluid retention
- Vertigo, dizziness
- Shortness of breath
- Arrhythmia
- Renal oedema
- Headache
- Hypertension
- Cardiovascular
- Urinary
- Central nervous
- Cardio-respiratory
CorrectIncorrect - Question 15 of 20
15. Question
Assertion: Fatigue is reported as a symptom in approximately 90% of myeloma patients at some point during the course of their disease
BECAUSE
Reason: Fatigue in a healthy individual resolves after rest and sleep
CorrectIncorrect - Question 16 of 20
16. Question
Assertion: The most common location for a thromboembolic event is the lung
BECAUSE
Reason: Myeloma patients with a family history of thromboembolic events are at greater risk of developing a deep vein thrombosis
CorrectIncorrect - Question 17 of 20
17. Question
Erythropoietin and immunoglobulin replacement therapy are commonly used as supportive treatments for myeloma patients
CorrectIncorrect - Question 18 of 20
18. Question
Can you match the symptoms associated with the different types of peripheral neuropathy?
Sort elements
- Motor neuropathy
- Autonomic neuropathy
- Sensory neuropathy
- Muscle weakness, cramping
- Postural hypotension, constipation
- Loss of sensation, tingling and numbness
CorrectIncorrect - Question 19 of 20
19. Question
The most effective way of treating myeloma-related renal impairment is to
CorrectIncorrect - Question 20 of 20
20. Question
Dose intensification is the initial recommended step in the management of treatment-related myelosuppression
CorrectIncorrect